- Title
- FXa-mediated PAR-2 promotes the efficacy of immunotherapy for hepatocellular carcinoma through immune escape and anoikis resistance by inducing PD-L1 transcription
- Creators
- Xuemei Li - Lanzhou University Second HospitalLei Gao - Lanzhou University Second HospitalBofang Wang - Lanzhou University Second HospitalJike Hu - Lanzhou UniversityYang Yu - Lanzhou UniversityBaohong Gu - Lanzhou UniversityLin Xiang - Lanzhou UniversityXiaomei Li - Lanzhou University Second HospitalHaiyuan Li - Lanzhou UniversityTao Zhang - First Hospital of Lanzhou UniversityYunpeng Wang - Lanzhou UniversityChenhui Ma - Lanzhou University Second HospitalJiahong Dong - Tsinghua UniversityJianrong Lu - Florida CollegeAlexandra Lucas - Arizona State UniversityHao Chen - Lanzhou University Second Hospital
- Publication Details
- Journal for immunotherapy of cancer, Vol.12(7), p.e009565
- Publisher
- BMJ Publishing Group
- Grant note
- GXH20230817-14 / ; CY2023-ZD01 / ; 2020JSCX0073; 2020SHFZ0039 / ; 2019RCXM020 / ; 22ZD6FA054 / ; 82160129 / ; lzuyxcx-2022-160; lzuyxcx-2022-45; lzuyxcx-2022-88 / ;
- Identifiers
- 991006105481202656
- Academic Unit
- Hospital Medicine
- Language
- English
- Resource Type
- Journal article
Journal article
FXa-mediated PAR-2 promotes the efficacy of immunotherapy for hepatocellular carcinoma through immune escape and anoikis resistance by inducing PD-L1 transcription
Journal for immunotherapy of cancer, Vol.12(7), p.e009565
07/25/2024
PMID: 39060025
Metrics
4 Record Views